

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.88853081 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.88853081 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60179756 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50327301 |
| 5 | detection of other organism (GO:0098543) | 4.36336936 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25084417 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.25084417 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 4.15983435 |
| 9 | detection of bacterium (GO:0016045) | 4.15749263 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.10307899 |
| 11 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.09213079 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.03555785 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.03555785 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.03555785 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.03555785 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.03555785 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.03555785 |
| 18 | regulation of mast cell degranulation (GO:0043304) | 3.75155200 |
| 19 | detection of external biotic stimulus (GO:0098581) | 3.65824350 |
| 20 | protein localization to endosome (GO:0036010) | 3.56804633 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53519738 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.53147864 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 3.50538606 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.41882750 |
| 25 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40890002 |
| 26 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.39760177 |
| 27 | synaptic vesicle maturation (GO:0016188) | 3.39477832 |
| 28 | response to muramyl dipeptide (GO:0032495) | 3.39477594 |
| 29 | respiratory burst (GO:0045730) | 3.38016127 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.37749231 |
| 31 | positive regulation of lamellipodium assembly (GO:0010592) | 3.28808016 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.27706347 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.27706347 |
| 34 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.25143398 |
| 35 | positive regulation of B cell differentiation (GO:0045579) | 3.24240620 |
| 36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23574378 |
| 37 | regulation of mast cell activation (GO:0033003) | 3.22678985 |
| 38 | response to type I interferon (GO:0034340) | 3.22550722 |
| 39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21252268 |
| 40 | microglial cell activation (GO:0001774) | 3.21035009 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.19339717 |
| 42 | macrophage activation (GO:0042116) | 3.19119913 |
| 43 | cellular response to zinc ion (GO:0071294) | 3.18259208 |
| 44 | response to interleukin-15 (GO:0070672) | 3.17351417 |
| 45 | regulation of ARF GTPase activity (GO:0032312) | 3.17297862 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16996561 |
| 47 | detection of biotic stimulus (GO:0009595) | 3.16946391 |
| 48 | germinal center formation (GO:0002467) | 3.16788899 |
| 49 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.12748034 |
| 50 | response to nerve growth factor (GO:1990089) | 3.12748034 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11802024 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.11042682 |
| 53 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10112340 |
| 54 | T-helper 1 type immune response (GO:0042088) | 3.09718014 |
| 55 | * Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.05101729 |
| 56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04456459 |
| 57 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.03267209 |
| 58 | regulation of ARF protein signal transduction (GO:0032012) | 3.02265346 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.01967599 |
| 60 | actin nucleation (GO:0045010) | 3.01490488 |
| 61 | * Fc-gamma receptor signaling pathway (GO:0038094) | 3.01406892 |
| 62 | * Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.01406892 |
| 63 | * immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.01406892 |
| 64 | regulation of T cell tolerance induction (GO:0002664) | 2.99415729 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 2.98653264 |
| 66 | regulation of antigen processing and presentation (GO:0002577) | 2.97082464 |
| 67 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96747837 |
| 68 | regulation of regulated secretory pathway (GO:1903305) | 2.96528257 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93407075 |
| 70 | positive thymic T cell selection (GO:0045059) | 2.93213522 |
| 71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92231898 |
| 72 | T cell migration (GO:0072678) | 2.89124287 |
| 73 | positive regulation of Rap GTPase activity (GO:0032854) | 2.87607051 |
| 74 | negative regulation of phagocytosis (GO:0050765) | 2.86882454 |
| 75 | cortical actin cytoskeleton organization (GO:0030866) | 2.86796257 |
| 76 | clathrin coat assembly (GO:0048268) | 2.86449876 |
| 77 | cellular response to interleukin-15 (GO:0071350) | 2.85969423 |
| 78 | mature B cell differentiation (GO:0002335) | 2.85348590 |
| 79 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.83757419 |
| 80 | leukocyte degranulation (GO:0043299) | 2.82325295 |
| 81 | locomotory exploration behavior (GO:0035641) | 2.82191169 |
| 82 | positive regulation of lamellipodium organization (GO:1902745) | 2.81503112 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81236303 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.81171393 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81004269 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 2.80907170 |
| 87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80630399 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.79948571 |
| 89 | positive regulation of type 2 immune response (GO:0002830) | 2.78302703 |
| 90 | negative regulation of innate immune response (GO:0045824) | 2.78140667 |
| 91 | positive regulation of histone deacetylation (GO:0031065) | 2.77914333 |
| 92 | N-acetylneuraminate metabolic process (GO:0006054) | 2.77623763 |
| 93 | tolerance induction (GO:0002507) | 2.75200858 |
| 94 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74233349 |
| 95 | positive regulation of leukocyte degranulation (GO:0043302) | 2.74008753 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73391563 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.72425138 |
| 98 | T cell selection (GO:0045058) | 2.72174757 |
| 99 | negative thymic T cell selection (GO:0045060) | 2.71724110 |
| 100 | leukocyte aggregation (GO:0070486) | 2.71620552 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.70229120 |
| 102 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69349924 |
| 103 | nerve growth factor signaling pathway (GO:0038180) | 2.68708202 |
| 104 | positive regulation of macrophage cytokine production (GO:0060907) | 2.67038882 |
| 105 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66851100 |
| 106 | response to host immune response (GO:0052572) | 2.66851100 |
| 107 | natural killer cell differentiation (GO:0001779) | 2.65516999 |
| 108 | response to peptidoglycan (GO:0032494) | 2.65442739 |
| 109 | positive regulation of mast cell degranulation (GO:0043306) | 2.65363122 |
| 110 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65363122 |
| 111 | negative regulation of interleukin-6 production (GO:0032715) | 2.64527253 |
| 112 | B cell mediated immunity (GO:0019724) | 2.64338323 |
| 113 | defense response to protozoan (GO:0042832) | 2.63429024 |
| 114 | thymic T cell selection (GO:0045061) | 2.62462794 |
| 115 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.61947180 |
| 116 | barbed-end actin filament capping (GO:0051016) | 2.60926774 |
| 117 | positive regulation of interferon-alpha production (GO:0032727) | 2.59672845 |
| 118 | negative regulation of interleukin-12 production (GO:0032695) | 2.59329463 |
| 119 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.58056973 |
| 120 | granulocyte activation (GO:0036230) | 2.56954387 |
| 121 | regulation of macrophage cytokine production (GO:0010935) | 2.56842154 |
| 122 | cellular extravasation (GO:0045123) | 2.56351516 |
| 123 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.55294192 |
| 124 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53706620 |
| 125 | actin filament polymerization (GO:0030041) | 2.53481957 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.52815925 |
| 127 | neutrophil activation (GO:0042119) | 2.52525659 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51398242 |
| 129 | negative T cell selection (GO:0043383) | 2.51260740 |
| 130 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50926917 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 2.50622432 |
| 132 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.50331974 |
| 133 | sodium ion export (GO:0071436) | 2.50073788 |
| 134 | regulation of erythrocyte differentiation (GO:0045646) | 2.49163978 |
| 135 | regulation of Rap GTPase activity (GO:0032317) | 2.49076534 |
| 136 | response to host (GO:0075136) | 2.48108447 |
| 137 | response to host defenses (GO:0052200) | 2.48108447 |
| 138 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.48108447 |
| 139 | regulation of leukocyte degranulation (GO:0043300) | 2.47687212 |
| 140 | response to protozoan (GO:0001562) | 2.46203789 |
| 141 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.45924942 |
| 142 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.44148681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.69738576 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.42972182 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.26080718 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.22933473 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.17203766 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05468508 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01923780 |
| 8 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.87279831 |
| 9 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.85404955 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84894083 |
| 11 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.82421501 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70511256 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.68760243 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66203579 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54220346 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51090897 |
| 17 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.42069873 |
| 18 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.41034060 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.36289708 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.30655814 |
| 21 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27241084 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.25038281 |
| 23 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.20159121 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17433976 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13944749 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.10756797 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07801325 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07665752 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02928927 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01427522 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98116613 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96789258 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94301184 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90091415 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87605608 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82968718 |
| 37 | * MYB_26560356_Chip-Seq_TH2_Human | 1.81501282 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77230299 |
| 39 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.75865042 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70288130 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.69962976 |
| 42 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67574810 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.67510370 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67057780 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65460539 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.64196964 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.62921302 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.62750847 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.60692009 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57507496 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56588977 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56358802 |
| 53 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50911550 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.50750678 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47364751 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47253756 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46813628 |
| 58 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45848517 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44415005 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42659318 |
| 61 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39251950 |
| 62 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38951707 |
| 63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37797741 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37155476 |
| 65 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.36921620 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36537001 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36344429 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34145926 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32953215 |
| 70 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32063163 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31833807 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30248503 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28474736 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27916589 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27866991 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27745635 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27637276 |
| 78 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25646422 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25509529 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25114647 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22292496 |
| 82 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.21570607 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18274583 |
| 84 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17298572 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15072255 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15055681 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14320588 |
| 88 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13893171 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12622867 |
| 90 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11971457 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11843581 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11815076 |
| 93 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.11660242 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11424388 |
| 95 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.09697059 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09456119 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08501738 |
| 98 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08295800 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03700266 |
| 100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03534264 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03496173 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03456566 |
| 103 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03297632 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02850148 |
| 105 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.00638992 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99638344 |
| 107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98454434 |
| 108 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.98397205 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98146479 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 0.97726392 |
| 111 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97655415 |
| 112 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96596676 |
| 113 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96578371 |
| 114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95441736 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94733023 |
| 116 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92427573 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91680106 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91476283 |
| 119 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90087613 |
| 120 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88208364 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83624494 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82313981 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80802625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.39931242 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.47661759 |
| 3 | MP0003724_increased_susceptibility_to | 3.47596902 |
| 4 | MP0004510_myositis | 3.19039915 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.02246733 |
| 6 | MP0005387_immune_system_phenotype | 2.73650507 |
| 7 | MP0001790_abnormal_immune_system | 2.73650507 |
| 8 | MP0001800_abnormal_humoral_immune | 2.63665622 |
| 9 | MP0003436_decreased_susceptibility_to | 2.56300263 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.53259011 |
| 11 | MP0000685_abnormal_immune_system | 2.52064886 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.49272265 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.47975407 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.40556773 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.33112907 |
| 16 | MP0006082_CNS_inflammation | 2.24772878 |
| 17 | MP0005671_abnormal_response_to | 2.21469066 |
| 18 | MP0002723_abnormal_immune_serum | 2.16005794 |
| 19 | MP0002419_abnormal_innate_immunity | 2.14919333 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.12144904 |
| 21 | MP0001819_abnormal_immune_cell | 2.11374801 |
| 22 | MP0008260_abnormal_autophagy | 2.07616956 |
| 23 | * MP0005025_abnormal_response_to | 2.00713276 |
| 24 | MP0009278_abnormal_bone_marrow | 2.00691273 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.95408408 |
| 26 | * MP0002398_abnormal_bone_marrow | 1.90224691 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.87256167 |
| 28 | MP0005451_abnormal_body_composition | 1.81483478 |
| 29 | * MP0000716_abnormal_immune_system | 1.75299974 |
| 30 | MP0003075_altered_response_to | 1.72861963 |
| 31 | MP0009785_altered_susceptibility_to | 1.70873626 |
| 32 | MP0004858_abnormal_nervous_system | 1.68726301 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.66438089 |
| 34 | MP0002405_respiratory_system_inflammati | 1.57020727 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.54806076 |
| 36 | MP0000604_amyloidosis | 1.54710927 |
| 37 | MP0005310_abnormal_salivary_gland | 1.49329396 |
| 38 | MP0002722_abnormal_immune_system | 1.44873757 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.44510086 |
| 40 | * MP0002429_abnormal_blood_cell | 1.43089109 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.42186131 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.40242056 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.38978286 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.35422686 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.35327677 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.34898437 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.34388675 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.34388675 |
| 49 | MP0009840_abnormal_foam_cell | 1.33772086 |
| 50 | MP0009764_decreased_sensitivity_to | 1.33096693 |
| 51 | MP0004947_skin_inflammation | 1.33055298 |
| 52 | MP0003635_abnormal_synaptic_transmissio | 1.30321182 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.28476470 |
| 54 | MP0003448_altered_tumor_morphology | 1.28192749 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.28075776 |
| 56 | MP0003329_amyloid_beta_deposits | 1.27454467 |
| 57 | MP0003690_abnormal_glial_cell | 1.19609304 |
| 58 | MP0005166_decreased_susceptibility_to | 1.19480887 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.19196266 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.17940153 |
| 61 | MP0003866_abnormal_defecation | 1.17697019 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.17556828 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.13096502 |
| 64 | MP0001873_stomach_inflammation | 1.12098962 |
| 65 | MP0004381_abnormal_hair_follicle | 1.11875664 |
| 66 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11056537 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.10006411 |
| 68 | MP0004130_abnormal_muscle_cell | 1.06070405 |
| 69 | MP0002132_abnormal_respiratory_system | 1.05528957 |
| 70 | MP0001853_heart_inflammation | 1.05417549 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.04912369 |
| 72 | MP0002064_seizures | 1.04280569 |
| 73 | * MP0000703_abnormal_thymus_morphology | 1.02690354 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.02143226 |
| 75 | MP0004883_abnormal_blood_vessel | 1.01605471 |
| 76 | MP0000343_altered_response_to | 0.98119723 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.97533694 |
| 78 | MP0002166_altered_tumor_susceptibility | 0.96472549 |
| 79 | MP0002733_abnormal_thermal_nociception | 0.96284794 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 0.96167040 |
| 81 | MP0002063_abnormal_learning/memory/cond | 0.96105653 |
| 82 | MP0000858_altered_metastatic_potential | 0.95788153 |
| 83 | MP0008874_decreased_physiological_sensi | 0.95651108 |
| 84 | MP0000920_abnormal_myelination | 0.95239483 |
| 85 | MP0008469_abnormal_protein_level | 0.91739305 |
| 86 | MP0004811_abnormal_neuron_physiology | 0.91573564 |
| 87 | MP0008569_lethality_at_weaning | 0.91267391 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.90862756 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.89654218 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.89464151 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.88478086 |
| 92 | MP0000490_abnormal_crypts_of | 0.86384417 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.85877737 |
| 94 | MP0001851_eye_inflammation | 0.85229148 |
| 95 | MP0009763_increased_sensitivity_to | 0.84103116 |
| 96 | MP0003091_abnormal_cell_migration | 0.84083811 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.83848894 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.83388178 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.81525108 |
| 100 | MP0010307_abnormal_tumor_latency | 0.80059042 |
| 101 | MP0004270_analgesia | 0.79590431 |
| 102 | MP0001970_abnormal_pain_threshold | 0.78352298 |
| 103 | MP0003828_pulmonary_edema | 0.75687045 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.75599397 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.74307710 |
| 106 | MP0003633_abnormal_nervous_system | 0.73864484 |
| 107 | MP0009046_muscle_twitch | 0.73735836 |
| 108 | MP0001663_abnormal_digestive_system | 0.73734769 |
| 109 | MP0005164_abnormal_response_to | 0.73370381 |
| 110 | MP0002006_tumorigenesis | 0.71623380 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.71407512 |
| 112 | MP0005390_skeleton_phenotype | 0.69899278 |
| 113 | MP0009745_abnormal_behavioral_response | 0.69139691 |
| 114 | MP0003795_abnormal_bone_structure | 0.68251264 |
| 115 | MP0003045_fibrosis | 0.66348063 |
| 116 | MP0008004_abnormal_stomach_pH | 0.65328676 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.64395097 |
| 118 | MP0000609_abnormal_liver_physiology | 0.63585588 |
| 119 | MP0003634_abnormal_glial_cell | 0.62834142 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.61110329 |
| 121 | MP0000371_diluted_coat_color | 0.60345471 |
| 122 | MP0000249_abnormal_blood_vessel | 0.57113536 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.55606311 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55311200 |
| 125 | MP0002254_reproductive_system_inflammat | 0.54868882 |
| 126 | MP0002933_joint_inflammation | 0.52465330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.46227993 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.33796128 |
| 3 | Orchitis (HP:0100796) | 4.14141121 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.03919878 |
| 5 | Cellulitis (HP:0100658) | 3.97751171 |
| 6 | Optic neuritis (HP:0100653) | 3.95202432 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.95202432 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.85712033 |
| 9 | Mutism (HP:0002300) | 3.46395281 |
| 10 | Chronic otitis media (HP:0000389) | 3.35453180 |
| 11 | Papilledema (HP:0001085) | 3.33651459 |
| 12 | Disinhibition (HP:0000734) | 3.30708812 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.26661657 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23116998 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.22683695 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18232162 |
| 17 | Obstructive lung disease (HP:0006536) | 3.18232162 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.12972986 |
| 19 | Apathy (HP:0000741) | 3.10594372 |
| 20 | Recurrent viral infections (HP:0004429) | 3.08797479 |
| 21 | Diminished motivation (HP:0000745) | 3.02108274 |
| 22 | Encephalitis (HP:0002383) | 3.01007813 |
| 23 | Colitis (HP:0002583) | 2.98610096 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 2.97135891 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.96690563 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96234347 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.95110157 |
| 28 | Pulmonary infiltrates (HP:0002113) | 2.93165310 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 2.89848657 |
| 30 | Agammaglobulinemia (HP:0004432) | 2.88358258 |
| 31 | Inflammation of the large intestine (HP:0002037) | 2.87531041 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.79515677 |
| 33 | Dysostosis multiplex (HP:0000943) | 2.76558220 |
| 34 | Recurrent skin infections (HP:0001581) | 2.75935285 |
| 35 | Verrucae (HP:0200043) | 2.72772406 |
| 36 | Papilloma (HP:0012740) | 2.72772406 |
| 37 | Pustule (HP:0200039) | 2.72446340 |
| 38 | Hemoptysis (HP:0002105) | 2.68058791 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66748888 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66748888 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66748888 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.65099153 |
| 43 | Meningitis (HP:0001287) | 2.60846801 |
| 44 | Visual hallucinations (HP:0002367) | 2.56389609 |
| 45 | Purpura (HP:0000979) | 2.55868077 |
| 46 | Amyloidosis (HP:0011034) | 2.55697723 |
| 47 | T lymphocytopenia (HP:0005403) | 2.54598074 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.54210553 |
| 49 | Neuronal loss in central nervous system (HP:0002529) | 2.50542806 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.49080349 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.47962862 |
| 52 | Inappropriate behavior (HP:0000719) | 2.47043705 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43072071 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43072071 |
| 55 | Loss of speech (HP:0002371) | 2.42396330 |
| 56 | Arterial thrombosis (HP:0004420) | 2.41018025 |
| 57 | Epistaxis (HP:0000421) | 2.39990158 |
| 58 | Hyperacusis (HP:0010780) | 2.39111151 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38478775 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.37706872 |
| 61 | Nasal polyposis (HP:0100582) | 2.37701236 |
| 62 | Increased IgM level (HP:0003496) | 2.36473751 |
| 63 | Diplopia (HP:0000651) | 2.34053711 |
| 64 | Abnormality of binocular vision (HP:0011514) | 2.34053711 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.33813336 |
| 66 | Episodic fever (HP:0001954) | 2.33740153 |
| 67 | IgM deficiency (HP:0002850) | 2.33482907 |
| 68 | Lymphopenia (HP:0001888) | 2.32268040 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.31793396 |
| 70 | Gingival bleeding (HP:0000225) | 2.31775925 |
| 71 | Amyotrophic lateral sclerosis (HP:0007354) | 2.31383451 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.30551896 |
| 73 | Increased serum ferritin (HP:0003281) | 2.30512717 |
| 74 | Pulmonary embolism (HP:0002204) | 2.27830434 |
| 75 | Leukocytosis (HP:0001974) | 2.27406829 |
| 76 | Axonal loss (HP:0003447) | 2.24309649 |
| 77 | Chest pain (HP:0100749) | 2.23628349 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.21986291 |
| 79 | Vasculitis (HP:0002633) | 2.21761444 |
| 80 | Abnormality of T cells (HP:0002843) | 2.21101552 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20648184 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.20648184 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19650906 |
| 84 | Achilles tendon contracture (HP:0001771) | 2.18254538 |
| 85 | Myokymia (HP:0002411) | 2.17796733 |
| 86 | Myositis (HP:0100614) | 2.15568888 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 2.14655908 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.11989772 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 2.09300947 |
| 90 | Gingivitis (HP:0000230) | 2.08524651 |
| 91 | Hypertensive crisis (HP:0100735) | 2.07607562 |
| 92 | Stomatitis (HP:0010280) | 2.06435736 |
| 93 | Emphysema (HP:0002097) | 2.05467181 |
| 94 | Panhypogammaglobulinemia (HP:0003139) | 2.04854466 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03343651 |
| 96 | Increased IgE level (HP:0003212) | 2.03155195 |
| 97 | Anorexia (HP:0002039) | 2.03008511 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.02136979 |
| 99 | Restrictive lung disease (HP:0002091) | 2.00893789 |
| 100 | Petechiae (HP:0000967) | 2.00422240 |
| 101 | Macroorchidism (HP:0000053) | 1.99784177 |
| 102 | Glomerulopathy (HP:0100820) | 1.99200024 |
| 103 | Granulocytopenia (HP:0001913) | 1.98914653 |
| 104 | Premature loss of primary teeth (HP:0006323) | 1.98097172 |
| 105 | Osteomyelitis (HP:0002754) | 1.97794751 |
| 106 | Polyneuropathy (HP:0001271) | 1.96751036 |
| 107 | Systemic lupus erythematosus (HP:0002725) | 1.95814768 |
| 108 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95192214 |
| 109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95192214 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95192214 |
| 111 | Urticaria (HP:0001025) | 1.94872350 |
| 112 | Slow saccadic eye movements (HP:0000514) | 1.94165289 |
| 113 | Rapidly progressive (HP:0003678) | 1.93979756 |
| 114 | Progressive neurologic deterioration (HP:0002344) | 1.93457464 |
| 115 | Neurofibrillary tangles (HP:0002185) | 1.92192514 |
| 116 | Hematochezia (HP:0002573) | 1.91359328 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.91295159 |
| 118 | Abnormality of the pleura (HP:0002103) | 1.91266741 |
| 119 | Viral hepatitis (HP:0006562) | 1.89656783 |
| 120 | Abnormality of the Achilles tendon (HP:0005109) | 1.89343796 |
| 121 | Cerebral aneurysm (HP:0004944) | 1.87578763 |
| 122 | Gangrene (HP:0100758) | 1.86052132 |
| 123 | Annular pancreas (HP:0001734) | 1.85649478 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84277328 |
| 125 | Akinesia (HP:0002304) | 1.79377007 |
| 126 | Abnormality of the lower motor neuron (HP:0002366) | 1.76627439 |
| 127 | Prolonged bleeding time (HP:0003010) | 1.76291691 |
| 128 | Increased density of long bones (HP:0006392) | 1.75775393 |
| 129 | Sepsis (HP:0100806) | 1.75178376 |
| 130 | Asymmetric septal hypertrophy (HP:0001670) | 1.74652769 |
| 131 | Hypercortisolism (HP:0001578) | 1.74302949 |
| 132 | Frequent falls (HP:0002359) | 1.74056079 |
| 133 | Fatigue (HP:0012378) | 1.73571258 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 1.73556427 |
| 135 | Impaired platelet aggregation (HP:0003540) | 1.70165727 |
| 136 | Abnormal platelet function (HP:0011869) | 1.70165727 |
| 137 | Pointed chin (HP:0000307) | 1.70052912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.70110433 |
| 2 | MAP4K1 | 3.54346528 |
| 3 | PRPF4B | 3.04838996 |
| 4 | MAP3K9 | 2.97410458 |
| 5 | RIPK4 | 2.89721852 |
| 6 | PKN2 | 2.58805220 |
| 7 | BLK | 2.47103069 |
| 8 | ERN1 | 2.20861383 |
| 9 | GRK6 | 2.19798899 |
| 10 | FES | 2.10294933 |
| 11 | SIK2 | 1.98686714 |
| 12 | MAP3K10 | 1.96131549 |
| 13 | SIK3 | 1.95596766 |
| 14 | SCYL2 | 1.95521129 |
| 15 | EEF2K | 1.89680628 |
| 16 | CSF1R | 1.74944015 |
| 17 | KSR2 | 1.74818333 |
| 18 | TYK2 | 1.67172436 |
| 19 | MARK1 | 1.64726053 |
| 20 | IRAK3 | 1.64236664 |
| 21 | SYK | 1.61210422 |
| 22 | TBK1 | 1.61126169 |
| 23 | LRRK2 | 1.57816123 |
| 24 | TXK | 1.55283479 |
| 25 | MAP3K3 | 1.52501820 |
| 26 | KIT | 1.52359486 |
| 27 | MATK | 1.51347200 |
| 28 | CAMKK1 | 1.49938841 |
| 29 | * ALK | 1.49854963 |
| 30 | EPHB1 | 1.49196175 |
| 31 | BMX | 1.47039746 |
| 32 | TAOK1 | 1.43959822 |
| 33 | STK10 | 1.39109564 |
| 34 | FGR | 1.38305129 |
| 35 | CSK | 1.33167829 |
| 36 | HCK | 1.32858477 |
| 37 | SMG1 | 1.28097688 |
| 38 | PAK6 | 1.24061198 |
| 39 | MAP3K13 | 1.19579173 |
| 40 | TAOK2 | 1.18075827 |
| 41 | JAK1 | 1.15849266 |
| 42 | TESK2 | 1.13941559 |
| 43 | PTK6 | 1.11414108 |
| 44 | BTK | 1.09186195 |
| 45 | NME2 | 1.07107178 |
| 46 | BMPR2 | 1.06770009 |
| 47 | ZAP70 | 1.05060801 |
| 48 | MINK1 | 1.02593193 |
| 49 | TYRO3 | 1.01822641 |
| 50 | PRKCH | 0.98634308 |
| 51 | RET | 0.96138589 |
| 52 | MAP3K11 | 0.93138728 |
| 53 | JAK3 | 0.91042598 |
| 54 | SIK1 | 0.90714987 |
| 55 | RIPK1 | 0.87021159 |
| 56 | IRAK4 | 0.84904078 |
| 57 | TGFBR2 | 0.83682226 |
| 58 | PDK1 | 0.83579227 |
| 59 | CDK12 | 0.83166416 |
| 60 | CDC42BPA | 0.80725613 |
| 61 | PIM2 | 0.80554182 |
| 62 | ICK | 0.79943574 |
| 63 | LCK | 0.78117926 |
| 64 | MAP2K3 | 0.76937195 |
| 65 | STK11 | 0.75818095 |
| 66 | MAP3K14 | 0.73875083 |
| 67 | DAPK2 | 0.72666130 |
| 68 | IRAK2 | 0.71963337 |
| 69 | TNK2 | 0.71273164 |
| 70 | LYN | 0.71064513 |
| 71 | CLK1 | 0.70893600 |
| 72 | DMPK | 0.70706959 |
| 73 | YES1 | 0.70482416 |
| 74 | MAP3K1 | 0.65880342 |
| 75 | ITK | 0.65385523 |
| 76 | * JAK2 | 0.65050441 |
| 77 | HIPK2 | 0.64467036 |
| 78 | MAP2K4 | 0.64243005 |
| 79 | FYN | 0.63388458 |
| 80 | MAP3K6 | 0.63297075 |
| 81 | UHMK1 | 0.61319739 |
| 82 | PDPK1 | 0.61177689 |
| 83 | NTRK1 | 0.60516540 |
| 84 | IKBKB | 0.58991904 |
| 85 | PRKD2 | 0.58934749 |
| 86 | CDK19 | 0.58682568 |
| 87 | TAOK3 | 0.58479818 |
| 88 | FGFR3 | 0.58266628 |
| 89 | CDK5 | 0.58066505 |
| 90 | IRAK1 | 0.57955120 |
| 91 | PRKCQ | 0.55818011 |
| 92 | DAPK1 | 0.55694746 |
| 93 | ARAF | 0.54978486 |
| 94 | PHKG2 | 0.54435235 |
| 95 | PHKG1 | 0.54435235 |
| 96 | RAF1 | 0.53684071 |
| 97 | GRK7 | 0.53006489 |
| 98 | MAP2K2 | 0.52263272 |
| 99 | GRK5 | 0.51720142 |
| 100 | MAPK4 | 0.51687999 |
| 101 | TEC | 0.50081955 |
| 102 | PIM1 | 0.47100429 |
| 103 | CHUK | 0.46870783 |
| 104 | CDK4 | 0.46389455 |
| 105 | CAMK1G | 0.46385607 |
| 106 | MARK2 | 0.46364050 |
| 107 | TTN | 0.45935676 |
| 108 | KSR1 | 0.45430667 |
| 109 | CDK6 | 0.44505626 |
| 110 | * EGFR | 0.44200824 |
| 111 | LIMK1 | 0.43983686 |
| 112 | MARK3 | 0.43658693 |
| 113 | MAP3K5 | 0.43587043 |
| 114 | MAPK7 | 0.43120360 |
| 115 | MAPKAPK2 | 0.43033612 |
| 116 | IKBKE | 0.43030620 |
| 117 | CDK14 | 0.42966822 |
| 118 | RPS6KA2 | 0.42950581 |
| 119 | CDK15 | 0.42892702 |
| 120 | PRKD1 | 0.42817058 |
| 121 | CAMKK2 | 0.42594002 |
| 122 | MAPK11 | 0.41897088 |
| 123 | CDK11A | 0.41270166 |
| 124 | MAPK12 | 0.39929119 |
| 125 | RPS6KC1 | 0.39691041 |
| 126 | RPS6KL1 | 0.39691041 |
| 127 | MAP3K8 | 0.39099159 |
| 128 | MAP2K6 | 0.38482285 |
| 129 | NTRK2 | 0.38280975 |
| 130 | TESK1 | 0.36957956 |
| 131 | FGFR4 | 0.36843178 |
| 132 | NTRK3 | 0.35696839 |
| 133 | SGK3 | 0.30672254 |
| 134 | DYRK1B | 0.30450682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 2.78177543 |
| 2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.77608836 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62327581 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53728047 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.49556874 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17883906 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13839206 |
| 8 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11372348 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.99490362 |
| 10 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.98126037 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.70263017 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68940271 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68923670 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.66467191 |
| 15 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59654052 |
| 16 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.58575521 |
| 17 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56212329 |
| 18 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.55492293 |
| 19 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55341839 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.54961651 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54703957 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.43556420 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40298967 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.39335021 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.37018606 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.33985971 |
| 27 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30895162 |
| 28 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30127195 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.28668807 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28003579 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26695313 |
| 32 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26254373 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.22526866 |
| 34 | Endocytosis_Homo sapiens_hsa04144 | 1.21884996 |
| 35 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.21128930 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16542288 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15460109 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.13832582 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11958731 |
| 40 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.11145893 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10689866 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10424399 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.09579546 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09360561 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 1.08724789 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07442826 |
| 47 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04901608 |
| 48 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03379122 |
| 49 | * Glioma_Homo sapiens_hsa05214 | 1.03186342 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01771677 |
| 51 | * Hepatitis C_Homo sapiens_hsa05160 | 1.00598386 |
| 52 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00419456 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99634262 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98329558 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96355791 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95169121 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93329001 |
| 58 | * Hepatitis B_Homo sapiens_hsa05161 | 0.93207940 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93204320 |
| 60 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91291482 |
| 61 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90418927 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90326252 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90280560 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.89601266 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88978966 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.88805398 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85750555 |
| 68 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85007263 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84299560 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84206624 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.84173922 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84121143 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82624881 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82355071 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.81459482 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80757311 |
| 77 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79966336 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78801998 |
| 79 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78668082 |
| 80 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76210889 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.75864758 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75630592 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75498986 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75097245 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73746310 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73109158 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72819854 |
| 88 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72228596 |
| 89 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72177323 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71396207 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.70731441 |
| 92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69890062 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69388556 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67976470 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67806746 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67778767 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67761595 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67659034 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.64859196 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64298462 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63918855 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63389753 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.63021526 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.62368712 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62264142 |
| 106 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.62193131 |
| 107 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61619767 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61599644 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61233886 |
| 110 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60396679 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60386364 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59974225 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59510834 |
| 114 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58345496 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55287329 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49815808 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47001502 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46306727 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.46226918 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46012425 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.44029178 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43427508 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37240982 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.35035299 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33061450 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29695994 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28289970 |
| 128 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27504977 |

